Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate cancer treatment – China's perspective
Jiazhou Liu, Liang Dong, Yinjie Zhu, et al.
Cancer Letters (2022) Vol. 550, pp. 215927-215927
Closed Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Multi-omics analysis and experimental validation of the value of monocyte-associated features in prostate cancer prognosis and immunotherapy
Yaxuan Wang, Chao Li, JiaXing He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Nanodelivery System of Traditional Chinese Medicine Bioactive Compounds: Application in the Treatment of Prostate Cancer
Bo Zou, Yan Long, Rui‐Song Gao, et al.
Phytomedicine (2024) Vol. 135, pp. 155554-155554
Open Access | Times Cited: 8
Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: A benchmarking study using ten machine learning methods and twelve patient cohorts
Wenjun Yin, Guo Chen, Yutong Li, et al.
Cancer Letters (2024) Vol. 588, pp. 216739-216739
Closed Access | Times Cited: 7
Trends of Prostate Cancer Morbidity in Low-Incidence Countries from 1990–2019
Jinjiang Jiang, Bo Chen, Bo Tang, et al.
Cancer Epidemiology Biomarkers & Prevention (2024) Vol. 33, Iss. 2, pp. 186-195
Open Access | Times Cited: 6
The role of miR-155 in urologic malignancies
Maolei Shen, Tao Chen, Xin Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116412-116412
Open Access | Times Cited: 5
Elucidating the role of pyrimidine metabolism in prostate cancer and its therapeutic implications
Liang Huang, Yu Xie, Shusuan Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring the Effects of Opioid-Related Drugs on the Clinical Outcome of Prostate Cancer Patients Via Integrated Bioinformatics Analysis
Yunxuan Zhang, Yuenan Liu, Kailei Chen, et al.
Molecular Biotechnology (2025)
Closed Access
Tegaserod maleate exerts anti-tumor effects on prostate cancer via repressing sonic hedgehog signaling pathway
Maoping Cai, Shengdong Ge, Yaying Hong, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
6-C-methylquercetin in Baeckea frutescens exerts anti-prostate cancer effect via ErbB/PI3K/AKT pathway
Beixi Jia, Mengyao Zhang, Xinyue Jiang, et al.
Phytomedicine (2025) Vol. 139, pp. 156463-156463
Closed Access
Organoid: Bridging the gap between basic research and clinical practice
Guihu Weng, Jinxin Tao, Yueze Liu, et al.
Cancer Letters (2023) Vol. 572, pp. 216353-216353
Closed Access | Times Cited: 13
Drp1: Focus on Diseases Triggered by the Mitochondrial Pathway
Fulin Sun, Min Fang, Huhu Zhang, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 435-455
Closed Access | Times Cited: 4
Prevalence and risk evaluation of cardiovascular disease in the newly diagnosed prostate cancer population in China: A nationwide, multi-center, population-based cross-sectional study
Weiyu Zhang, Huixin Liu, Ming Liu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 11, pp. 1324-1331
Open Access | Times Cited: 4
8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer
Yuankang Feng, Zhenlin Huang, Fubo Lu, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Laser-activated nanoparticles for ultrasound/photoacoustic imaging-guided prostate cancer treatment
Lin‐Kang Xiao, Yunfang Wu, Junyong Dai, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 8
Triglyceride-glucose index is a predictor of the risk of prostate cancer: a retrospective study based on a transprostatic aspiration biopsy population
Yijie Zhou, Tianqi Li, Guliman Muheiyati, et al.
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 2
Understanding Ganoderma lucidum (Curtis) P. Karst's multipronged potential in improving drug delivery methods and its application in the management prostate of cancer
Salik Abdullah, Vasudha Bakshi, Shreya Mukherjee, et al.
Pharmacological Research - Modern Chinese Medicine (2024), pp. 100554-100554
Open Access | Times Cited: 2
Machine learning based on radiomics features combing B-mode transrectal ultrasound and contrast-enhanced ultrasound to improve peripheral zone prostate cancer detection
Ya Sun, Jingyang Fang, Yan‐Ping Shi, et al.
Abdominal Radiology (2023) Vol. 49, Iss. 1, pp. 141-150
Open Access | Times Cited: 7
Analysis of risk factors leading to anxiety and depression in patients with prostate cancer after castration and the construction of a risk prediction model
Rui-Xiao Li, Xuelian Li, Guojun Wu, et al.
World Journal of Psychiatry (2024) Vol. 14, Iss. 2, pp. 255-265
Open Access | Times Cited: 1
Reliability and validity tests of the Chinese version of the Geriatric Locomotive Function Scale (GLFS-25) in tumor survivors
Yuling Yang, Hui-Hong Wang, Hui Su, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e29604-e29604
Open Access | Times Cited: 1
Efficacy of brachytherapy versus radical prostatectomy for localized prostate cancer–propensity score-matched comparison
Zaisheng Zhu, Zhu Yi-Yi, Hongqi Shi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
China ARCHES: A Phase 3 Trial of Enzalutamide vs Placebo in Metastatic Hormone-Sensitive Prostate Cancer
Y. H. Chang, Yonghong Li, Gongqian Zeng, et al.
JU Open Plus (2024) Vol. 2, Iss. 10
Open Access | Times Cited: 1
Research progress on the role of lipoxygenase and its inhibitors in prostate cancer
Xiaobing Li, Jingxin Mao
Future Oncology (2024), pp. 1-20
Closed Access | Times Cited: 1
Osteoblast‐Derived ECM1 Promotes Anti‐Androgen Resistance in Bone Metastatic Prostate Cancer
Xin-wen Wang, Min Wang, Qijun Lin, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Combination of metabolomics and network pharmacology analysis to decipher the mechanisms of total flavonoids of Litchi seed against prostate cancer
Dianxin Cui, Zhuo Luo, Xi Liu, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 7, pp. 951-968
Closed Access | Times Cited: 4
Crosstalk between Endothelial Cells and Tumor Cells: A New Era in Prostate Cancer Progression
Shiyu Ji, Wenbo Wu, Qi Jiang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16893-16893
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top